Holdings

Venrock Adviser, LLC

As of Sep 30, 2026, Venrock Adviser, LLC reported 31 positions worth US$1.82B. Largest: Oruka Therapeutics, Inc., Erasca, Inc. and Spyre Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Oruka Therapeutics, Inc.4.15MUS$346Mno changeSep 30, 2026
Erasca, Inc.20.1MUS$295M+2.2MSep 30, 2026
Spyre Therapeutics, Inc.2.49MUS$221M−500KSep 30, 2026
Savara, Inc.19.6MUS$101M+4.82MSep 30, 2026
Ocular Therapeutix, Inc.10.3MUS$79.4Mno changeSep 30, 2026
Dianthus Therapeutics, Inc.822KUS$72.4M−358KSep 30, 2026
Viridian Therapeutics, Inc.3.26MUS$67.1Mno changeSep 30, 2026
Vor Biopharma Inc.3.04MUS$58Mno changeSep 30, 2026
Cogent Biosciences, Inc.1.64MUS$52.6Mno changeSep 30, 2026
Adlai Nortye Group Ltd.3.21MUS$51.4MnewSep 30, 2026